title: The role of screening blood tests in patients with arterial disease attending vascular outpatients.
abstract: OBJECTIVE
  To evaluate the benefits of a policy of performing screening blood tests in new patients with arterial disease referred to the vascular outpatients department.
  
  
  METHODS
  Clinical audit over a 12-month period of all new referrals with arterial disease to the vascular outpatients department at the Leicester General Hospital.
  
  
  RESULTS
  Two hundred and seventy-two patients had at least one blood test performed at their outpatient visit. All of these patients had a full blood count performed, of which 21 results (21%) were abnormal. Further investigation of patients with abnormal results revealed one case of bladder cancer, one case of leukaemia and one patient with polycythaemia. Urea and electrolytes were measured in 269 patients (99%). Of these, 26 (10%) were expectedly abnormal in patients with known renal impairment. A further 27 patients (10%) were identified to have some degree of unrecognised renal impairment. Serum non-fasting glucose was measured in 252 patients (93%). There were 11 unexpectedly raised results, but further investigation of these patients only diagnosed one of these patients as diabetic. Serum cholesterol was measured in 201 patients (74%). One hundred and thirty-two patients (66%) had an abnormally raised serum cholesterol level. Of these, only 12 patients (6%) were known to have hyperlipidaemia.
  
  
  CONCLUSIONS
  Screening new patients with arterial disease in vascular outpatients does identify significant abnormalities, in particular renal impairment and hyperlipidaemia. Correction of these abnormalities may reduce the morbidity associated with contrast induced nephrotoxic acute renal failure, and also contribute to secondary prevention of vascular events associated with raised lipids.
authors.affiliation: Department of Vascular Surgery, Leicester General Hospital NHS Trust, U.K.
authors.forename: R
authors.initials: R
authors.lastname: Pararajasingam
authors.forename: A
authors.initials: A
authors.lastname: Nasim
authors.forename: C
authors.initials: C
authors.lastname: Sutton
authors.forename: M J
authors.initials: MJ
authors.lastname: Dennis
authors.forename: P R
authors.initials: PR
authors.lastname: Bell
authors.forename: R D
authors.initials: RD
authors.lastname: Sayers
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000554:Ambulatory Care Facilities; D001157:Arterial Occlusive Diseases / Q000097:blood / Q000150:complications*; D001772:Blood Cell Count / Q000191:economics; D001774:Blood Chemical Analysis / Q000191:economics; D003365:Costs and Cost Analysis; D003955:Diagnostic Tests, Routine / Q000191:economics; D005260:Female; D006801:Humans; D006949:Hyperlipidemias / Q000150:complications / Q000175:diagnosis; D007674:Kidney Diseases / Q000150:complications / Q000175:diagnosis; D008297:Male; D008875:Middle Aged; D012017:Referral and Consultation